Animal derived surfactant extract versus protein free synthetic surfactant for the prevention and treatment of respiratory distress syndrome-Reference-Cited by-同舟云学术

Animal derived surfactant extract versus protein free synthetic surfactant for the prevention and treatment of respiratory distress syndrome

Published:2015-08-24 Issue: Volume: Page:
ISSN:1465-1858
Container-title:Cochrane Database of Systematic Reviews
language:en
Short-container-title:

Author:

Ardell Stephanie¹,Pfister Robert H²,Soll Roger³

Affiliation:

1. University of Pittsburgh Medical Center; Pediatrics Division of Newborn Medicine; 300 Halket Street Pittsburgh Pennsylvania USA 15219

2. St Charles Health Care; Division of Neonatology; 2500 NE Neff Rd Bend Oregon USA 97701

3. University of Vermont Medical Center; Division of Neonatal-Perinatal Medicine; 111 Colchester Avenue Burlington Vermont USA 05401

Publisher

Wiley

Subject

Pharmacology (medical)

Link

http://onlinelibrary.wiley.com/wol1/doi/10.1002/14651858.CD000144.pub3/fullpdf

Reference67 articles.

1. Pumactant and poractant alfa for treatment of respiratory distress syndrome in neonates born at 25-29 weeks' gestation: a randomised trial;Ainsworth;Lancet,2000

2. Clinical trial of survanta versus exosurf in infants < 1500g with respiratory distress syndrome;Alvarado;Pediatric Research,1993

3. Comparative trial of artificial and natural surfactants in the treatment of respiratory distress syndrome of prematurity: experiences in a developing country;daCosta;Pediatric Pulmonology,1999

4. Halahakoon WL A study of cerebral function following surfactant treatment for respiratory distress syndrome (Doctoral dissertation) Queen's University of Belfast (UK) 1999

5. A multicenter randomized trial comparing two surfactants for the treatment of neonatal respiratory distress syndrome. National Institute of Child Health and Human Development Neonatal Research Network;Horbar;Journal of Pediatrics,1993

Cited by 52 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Use of surfactant beyond respiratory distress syndrome, what is the evidence?;Journal of Perinatology;2024-03-08

2. Laryngeal mask airway surfactant administration for prevention of morbidity and mortality in preterm infants with or at risk of respiratory distress syndrome;Cochrane Database of Systematic Reviews;2024-01-25

3. Structural determinants of collapse by a monomolecular mimic of pulmonary surfactant at the physiological temperature;Soft Matter;2024

4. Synthetic surfactants;Seminars in Fetal and Neonatal Medicine;2023-12

5. Surfactant therapy guided by tests for lung maturity in preterm infants at risk of respiratory distress syndrome;Cochrane Database of Systematic Reviews;2023-10-26